Issued Patents 2025
Showing 1–4 of 4 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12403178 | Use of CD33CAR modified high affinity NK cells (t-haNK) to reduce myeloid-derived suppressor cells suppressor activity (or reduce negative impact on NK cell activity) | Patrick Soon-Shiong, Hans G. Klingemann, Himani Chinnapen, Abhijit Dandapat | 2025-09-02 |
| 12384852 | Genetically modified NK-92 cells having a safety switch | Tien Lee, Hans G. Klingemann, Barry J. Simon, Kerry S. Campbell | 2025-08-12 |
| 12378300 | Elimination of CD19-positive lymphoid malignancies by CD19-car expressing NK cells | Hans G. Klingemann, Patrick Soon-Shiong | 2025-08-05 |
| 12365874 | Chimeric antigen receptor-modified NK-92 cells targeting EGFR super-family receptors | John H. Lee, Hans G. Klingemann | 2025-07-22 |